论文部分内容阅读
医院每天消耗大量的药品,而每一药品均可能伴随着不安全因素,因此,药品安全性监控在药品管理中显得十分重要。设立ADRs(药物不良反应监察)监控小组,定期对ADRs病例报告进行讨论和因果关系分析评价,是我们做好ADRs监测的主要任务。通过分析、采纳所获得的药品安全信息,可以帮助医生、其他医务人员、社区保健人员更安全地处方用药。同时希望药品消费者提高自我保护意识,积极向医院ADRs监测小组或当地ADRs监测中心报告可疑的ADRs,而检测小组、药品生产商、医务人员可进行多方面合作,共同对上市药品进行ADRs监测,以使药品使用更为安全,恰当地改变患者对药品安全的忧虑,做到效益/风险平衡,对保护消费者健康权益尤为重要。
Hospitals consume a large amount of drugs daily, and each drug may be accompanied by insecurity, therefore, drug safety monitoring in the management of drugs appears to be very important. The establishment of ADRs surveillance teams to conduct regular reviews and causal analysis of ADRs case reports is the main focus of our monitoring of ADRs. By analyzing and adopting the obtained drug safety information, doctors, other medical staffs and community health workers can be prescribed drugs more safely. At the same time, drug users are expected to raise their awareness of self-protection and actively report suspicious ADRs to hospital ADRs monitoring groups or local ADRs monitoring centers. The testing teams, drug manufacturers and medical personnel can conduct various cooperation to jointly monitor ADRs of listed drugs, So as to make the use of drugs safer and properly change the patient’s concerns about drug safety so as to achieve the benefit / risk balance. This is especially important for protecting the health rights and interests of consumers.